Trials / Recruiting
RecruitingNCT07368647
Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Rachel A. Moses · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hyperbaric Oxygen Therapy | Hyperbaric Oxygen Therapy (HBOT) is the only non-invasive treatment modality for Radiation Cystitis, performed by placing patients in chambers and introducing them to steep oxygen gradients (100% oxygen at a pressure of 240-250kPa) for 80 to 90 minutes per day in up to 60 consecutive sessions. |
Timeline
- Start date
- 2022-04-04
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2026-01-26
- Last updated
- 2026-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07368647. Inclusion in this directory is not an endorsement.